The MGTX Trial

Research Webinar: Update on RozanolixizumabПодробнее

The Mongersen TrialПодробнее

The STOP-IT TrialПодробнее

TrialПодробнее

2016 MGFA National Conference MG Thymectomy Trial ResultsПодробнее

Said Beydoun, AAN 2019 – Current and emerging therapies for myasthenia gravis (Part 2)Подробнее

Navigating the Changing Landscape in Myasthenia Gravis: An Expert Case-Based DiscussionПодробнее

MGFA Webinar Series: Thymectomy or Not?Подробнее

MASTERKEY-265: Phase 1b/3 trial of T-VEC and pembrolizumab for unresectable stage IIIB-IV melanomaПодробнее

BOREAS trial: disease-modifying activity of navtemadlin in JAK-inhibitor R/R myelofibrosisПодробнее

Analysis of the IMerge trial: the disease-modifying potential of imetelstat in LR-MDSПодробнее

Research and Clinical Trials for MGПодробнее

The MG Patient Registry: Supporting the Vision of a World Without MGПодробнее

#54 To thymectomize or Not to thymectomize...That is the questionПодробнее

An Overview of the MA17R Trial in Breast CancerПодробнее

Update on the CART19-BE-02 trialПодробнее

Academic Research in Myasthenia Gravis: From Securing Funding to Reporting New FindingsПодробнее

Research Updates in Myasthenia GravisПодробнее

Case studies: Real world examples of how labs can use HGMD Professional to mitigate errors in...Подробнее